Close Menu
Home » Vanderbilt Spins Out Nashville Biosciences to Offer BioVU, PheWAS Services to Pharma

Vanderbilt Spins Out Nashville Biosciences to Offer BioVU, PheWAS Services to Pharma

Apr 04, 2018
|
Neil Versel
Premium

CHICAGO (GenomeWeb) – Vanderbilt University Medical Center in Nashville, Tennessee, is putting its genomics and bioinformatics expertise behind a newly unveiled commercial entity offering services and technology to the pharmaceutical and diagnostics industries.

Called Nashville Biosciences, the wholly owned subsidiary of Vanderbilt will lean heavily on BioVU, Vanderbilt's bank of longitudinal medical records and DNA samples that now contains more than 250,000 specimens.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Scan

Cost of a Visa

The Guardian reports that visa costs could prevent scientists and others from coming to the UK.

Rethinking Access Order

The Trump Administration is reconsidering its plan to issue an executive order to require federally funded research to be freely available upon publication, Times Higher Education reports.

May Have to Close

Nature News says some preprint repositories may close down due to a lack of funds to cover costs.

Nature Papers Present Way to Analyze Cancer Mutational Signatures, Explore Treatment Resistance in Lung Cancer, More

In Nature this week: framework for analyzing cancer mutational signatures, treatment resistance in small cell lung cancer followed by increased intratumoral heterogeneity, and more.

Mar
18
Featured Webinar

Comparison of Genome-Wide versus Targeted cfDNA Testing for First-Line Prenatal Screening: Real-World Data

Sponsored by
Roche

This webinar will discuss data from a recent real-world comparison study evaluating performance of two cell-free DNA methodologies as first-line prenatal screens.

Mar
31
Featured Webinar

The Role of Single-Cell Functional Biomarkers in Next-Generation Cancer Therapies

Sponsored by
Isoplexis

This webinar will discuss the application of single-cell proteomics and immune-imaging in adoptive cell therapy (ACT) for cancer.

What's Popular?

In Informatics

  1. Euformatics, Bio.logis Form Pharmacogenomics Alliance

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.